For instance, a high level of tumor-infiltrating lymphocytes correlates with good prognosis,16 whereas HER2-enriched tumors by gene expression profiling are characterized by optimal response to anti-HER2 therapy.17 The gene discussed is ERBB2; the disease is neoplasm.